Skip to main content
Clinical Trials/ACTRN12622001192774
ACTRN12622001192774
Not Yet Recruiting
N/A

To assess the effects of using heart rate variability and physical activity as an intervention in the management of fatigue in those who suffer fatigue as a primary or secondary symptom.

Specialised Health - Exercise Physiology0 sites80 target enrollmentSeptember 6, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Chronic fatigue
Sponsor
Specialised Health - Exercise Physiology
Enrollment
80
Status
Not Yet Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 6, 2022
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Specialised Health - Exercise Physiology

Eligibility Criteria

Inclusion Criteria

  • Individuals who meet the Fukuda and International Consensus Criteria for chronic fatigue or have been diagnosed with chronic fatigue by their GP or treating specialist. Individuals with secondary fatigue, such as long covid, post cancer fatigue, and fibromyalgia will also be accepted into the research study, if they have been diagnosed by a GP or specialist.

Exclusion Criteria

  • Individuals who have not been diagnosed with a fatigue condition and who do not meet the Fukuda, and International Consensus Criteria. Participants will be asked to only complete exercise as directed by the Clinical Exercise Physiologist across the 12 weeks of the study. The participants should continue to take any medications already prescribed.

Outcomes

Primary Outcomes

Not specified

Similar Trials